Lexicon Pharmaceuticals | LXRX - Passivo Circulante





Passivo Circulante Alterar Data
Abbott USD 18.38B 1.88B 2026-03
Acadia Pharmaceuticals USD 361.44M 55.91M 2026-06
Agios Pharmaceuticals USD 70.22M 11.37M 2026-06
Akebia Therapeutics USD 160.86M 13.02M 2026-06
Alnylam Pharmaceuticals USD 1.51B 163.04M 2026-06
AstraZeneca USD 31.55B 1.02B 2026-06
BioMarin Pharmaceutical USD 1.66B 870.84M 2026-06
Coherus Biosciences USD 75.51M 56.82M 2026-06
Eli Lilly USD 47.74B 11.11B 2026-06
Halozyme Therapeutics USD 344.44M 18.77M 2026-06
Illumina USD 1.58B 12M 2026-06
Insmed USD 438.74M 77.74M 2026-06
Ironwood Pharmaceuticals USD 236.31M 5.91M 2026-03
J&J USD 55.46B 562M 2026-09
Lexicon Pharmaceuticals USD 9.9M 10.97M 2026-03
MacroGenics USD 108.82M 12.88M 2026-06
MannKind USD 142.9M 8.34M 2026-06
Merck USD 27.73B 786M 2026-06
Moderna USD 2.53B 139M 2026-06
Novartis USD 31.75B 374M 2026-06
PTC Therapeutics USD 771.07M 152.54M 2026-06
Puma Biotechnology USD 82.73M 3.63M 2025-09
Sarepta Therapeutics USD 502.91M 3.74M 2026-06
Thermo Fisher Scientific USD 14.17B 899M 2026-09
Ultragenyx Pharmaceutical USD 351M 26M 2026-06
United Therapeutics USD 607.8M 8.7M 2026-06
Vanda Pharmaceuticals USD 145.16M 27.29M 2025-12